Market Cap 6.85M
Revenue (ttm) 620,000.00
Net Income (ttm) -46.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,564.52%
Debt to Equity Ratio 0.00
Volume 308,700
Avg Vol 1,725,064
Day's Range N/A - N/A
Shares Out 3.60M
Stochastic %K 18%
Beta 1.26
Analysts Hold
Price Target $45.00

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 438 1036
Website: co-dx.com
Address:
2401 S. Foothill Dr., Suite D, Salt Lake City, United States
CoffeeRocks
CoffeeRocks May. 13 at 11:32 AM
$CODX back to 2.6$
1 · Reply
Antiquarian
Antiquarian May. 13 at 10:27 AM
0 · Reply
Minutiae
Minutiae May. 13 at 5:49 AM
$CODX May 12 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae May. 13 at 5:48 AM
$CODX May 12 CODX volume 308,799 closing at $1.72. The chart begins shortly after 9:30 am to prevent premarket volume from dwarfing day volumes. 4,180 after-market shares trading at $1.71 to $1.84. FINRA Short Sale Volume 84,056 shorted shares out of 142,288. CODX short volume 59%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
Antiquarian
Antiquarian May. 13 at 12:42 AM
0 · Reply
Minutiae
Minutiae May. 12 at 11:59 PM
$CODX This May 12, 2026 prospectus gives Co-Dx free reign to dilute CODX shares, furthering the loss of share value already caused by the 30-to-1 reverse split. I have a large investment in CODX shares which has already been greatly diluted. This prospectus makes my very costly investment nearly worthless. I am very disturbed and angered by the loss I will experience in my investment caused by such further extreme CODX share dilution. The potential for a huge CODX share dilution makes investment in additional CODX shares today very undesirable. https://www.sec.gov/Archives/edgar/data/1692415/000149315226022504/forms-3.htm
1 · Reply
Antiquarian
Antiquarian May. 12 at 11:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 8:54 PM
0 · Reply
Millones
Millones May. 12 at 8:50 PM
$CODX New SEC filing: http://archive.fast-edgar.com/20260512/A32ER22CZM2RIJM2222S2ZY2HGBRZZ22Q282/ From time to time, we may offer and sell up to $150,000,000 of any combination of the securities described in this prospectus, either individually or in combination. We may also offer shares of common stock or preferred stock upon conversion of debt securities, shares of common stock upon conversion of preferred stock, or shares of common stock, shares of preferred stock or debt securities upon the exercise of warrants. Our common stock is listed on the Nasdaq Capital Market under the symbol “CODX.” On May 11, 2026, the last reported sale price for our common stock was $1.90 per share. The applicable prospectus supplement will contain information, where applicable, as to any other listing on the Nasdaq Capital Market or any securities market or other exchange of the securities, if any, covered by the prospectus supplement.
1 · Reply
Pig2market
Pig2market May. 12 at 7:33 PM
$CODX kiss this trash goodbye. Its done. Back to the gutter.
0 · Reply
Latest News on CODX
Co-Diagnostics files $150M mixed securities shelf

2026-05-12T20:55:31.000Z - 16 hours ago

Co-Diagnostics files $150M mixed securities shelf


Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 6 weeks ago

Co-Diagnostics Earnings Call Transcript: Q4 2025


Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 31, 2026, 4:01 PM EDT - 6 weeks ago

Co-Diagnostics Reports Full Year 2025 Financial Results


Co-Diagnostics to Present at Medical Korea 2026

Mar 16, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics to Present at Medical Korea 2026


Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

2026-01-23T14:10:52.000Z - 3 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting


Co-Diagnostics downgraded to Hold from Buy at Maxim

2026-01-23T13:00:47.000Z - 3 months ago

Co-Diagnostics downgraded to Hold from Buy at Maxim


Co-Diagnostics trading resumes

2026-01-13T17:30:17.000Z - 4 months ago

Co-Diagnostics trading resumes


Co-Diagnostics trading halted, volatility trading pause

2026-01-13T17:25:15.000Z - 4 months ago

Co-Diagnostics trading halted, volatility trading pause


Co-Diagnostics trading halted, news pending

2026-01-01T00:50:09.000Z - 4 months ago

Co-Diagnostics trading halted, news pending


Co-Diagnostics announces 1-for-30 reverse stock split

2025-12-30T14:10:33.000Z - 4 months ago

Co-Diagnostics announces 1-for-30 reverse stock split


Co-Diagnostics Announces Reverse Stock Split

Dec 30, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Announces Reverse Stock Split


Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025


Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:01 PM EST - 6 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results


Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 11:00 AM EST - 6 months ago

Co-Diagnostics Transcript: Fireside Chat


Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Oct 13, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit


Co-Diagnostics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 9 months ago

Co-Diagnostics Earnings Call Transcript: Q2 2025


Co-Diagnostics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q1 2025


Co-Diagnostics Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q4 2024


Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results


CoffeeRocks
CoffeeRocks May. 13 at 11:32 AM
$CODX back to 2.6$
1 · Reply
Antiquarian
Antiquarian May. 13 at 10:27 AM
0 · Reply
Minutiae
Minutiae May. 13 at 5:49 AM
$CODX May 12 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae May. 13 at 5:48 AM
$CODX May 12 CODX volume 308,799 closing at $1.72. The chart begins shortly after 9:30 am to prevent premarket volume from dwarfing day volumes. 4,180 after-market shares trading at $1.71 to $1.84. FINRA Short Sale Volume 84,056 shorted shares out of 142,288. CODX short volume 59%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
Antiquarian
Antiquarian May. 13 at 12:42 AM
0 · Reply
Minutiae
Minutiae May. 12 at 11:59 PM
$CODX This May 12, 2026 prospectus gives Co-Dx free reign to dilute CODX shares, furthering the loss of share value already caused by the 30-to-1 reverse split. I have a large investment in CODX shares which has already been greatly diluted. This prospectus makes my very costly investment nearly worthless. I am very disturbed and angered by the loss I will experience in my investment caused by such further extreme CODX share dilution. The potential for a huge CODX share dilution makes investment in additional CODX shares today very undesirable. https://www.sec.gov/Archives/edgar/data/1692415/000149315226022504/forms-3.htm
1 · Reply
Antiquarian
Antiquarian May. 12 at 11:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 8:54 PM
0 · Reply
Millones
Millones May. 12 at 8:50 PM
$CODX New SEC filing: http://archive.fast-edgar.com/20260512/A32ER22CZM2RIJM2222S2ZY2HGBRZZ22Q282/ From time to time, we may offer and sell up to $150,000,000 of any combination of the securities described in this prospectus, either individually or in combination. We may also offer shares of common stock or preferred stock upon conversion of debt securities, shares of common stock upon conversion of preferred stock, or shares of common stock, shares of preferred stock or debt securities upon the exercise of warrants. Our common stock is listed on the Nasdaq Capital Market under the symbol “CODX.” On May 11, 2026, the last reported sale price for our common stock was $1.90 per share. The applicable prospectus supplement will contain information, where applicable, as to any other listing on the Nasdaq Capital Market or any securities market or other exchange of the securities, if any, covered by the prospectus supplement.
1 · Reply
Pig2market
Pig2market May. 12 at 7:33 PM
$CODX kiss this trash goodbye. Its done. Back to the gutter.
0 · Reply
mexx
mexx May. 12 at 6:41 PM
$CODX sold! neutral again
1 · Reply
ricky_lafleur
ricky_lafleur May. 12 at 5:59 PM
$CODX wen 30 $
0 · Reply
mexx
mexx May. 12 at 5:49 PM
$CODX 👇
0 · Reply
mexx
mexx May. 12 at 5:46 PM
$CODX offering $1.50
0 · Reply
coolmate25
coolmate25 May. 12 at 3:43 PM
$CODX U.S. stock indexes are trading lower on Tuesday, May 12, 2026, as investors react to hotter-than-expected inflation data and geopolitical tensions. Market sentiment is pressured by a surge in oil prices following President Trump's comments on the U.S.-Iran ceasefire.
2 · Reply
mexx
mexx May. 12 at 3:31 PM
$CODX Have a look at the Y-axis. Who failed more than Dwight? David Hasselhof? Elizabeth Holmes? Charlie Sheen?
1 · Reply
mexx
mexx May. 12 at 3:16 PM
$CODX On a scale from 1–10 (10 = very happy), how satisfied are you with the company? What’s your honest sentiment? Drop your opinion below 👇
3 · Reply
Millones
Millones May. 12 at 2:18 PM
$CODX Short sale restricted today, not that it has ever mattered. https://www.nasdaqtrader.com/dynamic/symdir/shorthalts/shorthalts20260512.txt
1 · Reply
CoffeeRocks
CoffeeRocks May. 12 at 12:29 PM
1 · Reply
insanitywolftrading
insanitywolftrading May. 12 at 10:52 AM
$CODX They have the system to do rapid tests for Hanta, they need an EUA. They got an EUA for Covid. The EAU would instantly turn this into a massively profitable company and the share price could go up thousands of percent. Or, nothing happens and the company fails. High risk, high reward.
1 · Reply
mexx
mexx May. 12 at 10:23 AM
0 · Reply
Antiquarian
Antiquarian May. 12 at 9:49 AM
0 · Reply